OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
703
Results
Show all
Save search
Copy query
Show results for
Unknown
(548)
Genomics
(124)
Transcriptomics
(14)
Proteomics
(9)
Models
(5)
Metabolomics
(2)
Other
(1)
Organisms
Homo sapiens
(13)
Mus musculus
(7)
Rattus norvegicus
(2)
Hippoglossoides platessoides
(1)
Saccharomyces cerevisiae
(1)
Drosophila melanogaster
(1)
Arabidopsis thaliana
(1)
Candida albicans
(1)
Bothrops cotiara
(1)
Escherichia coli
(1)
Theileria annulata
(1)
Organisms
Homo sapiens
(65)
Mus musculus
(28)
Plasmodium falciparum Dd2
(2)
synthetic construct
(2)
Gallus gallus
(2)
Leishmania infantum
(1)
Francisella tularensis subsp. tularensis SCHU S4
(1)
Dasypus novemcinctus
(1)
Taxus x media
(1)
Mitragyna speciosa
(1)
Cricetulus griseus
(1)
Chlorocebus aethiops
(1)
Dendrobaena veneta
(1)
Candida albicans
(1)
Staphylococcus aureus
(1)
Repository
ENA
(120)
biostudies-arrayexpress
(14)
pride
(8)
BioModels
(5)
geo
(4)
MetaboLights
(2)
EGA
(1)
iProX
(1)
Tissue
Epithelial cell
(2)
B cell
(1)
Cell culture
(1)
Dendritic cell
(1)
Hepatocyte
(1)
Liver
(1)
Macrophage
(1)
Venom
(1)
Disease
Breast cancer
(2)
Hepatocellular carcinoma
(1)
Parasitic protozoa infectious disease
(1)
Tuberculosis
(1)
Technology Type
Mass Spectrometry
(8)
Bottom-up proteomics
(3)
Mass spectrometry
(2)
Illumina HiSeq 2500, ILLUMINA
(1)
Data-dependent acquisition
(1)
Data-independent acquisition
(1)
Immunopeptidomics
(1)
Shotgun proteomics
(1)
Top-down proteomics
(1)
Instrument Platform
Gas Chromatography MS - positive
(2)
TruSeq RNA Sample Preparation protocol
(1)
Illumina HiSeq 2500
(1)
Illumina NovaSeq 6000
(1)
Liquid Chromatography MS - negative - reverse phase
(1)
Liquid Chromatography MS - positive - reverse phase
(1)
Publication Date
2024
(8)
2026
(6)
2025
(5)
2016
(2)
2013
(2)
2011
(2)
2008
(2)
2023
(2)
2015
(1)
2012
(1)
2009
(1)
2007
(1)
2021
(1)
CHEBI ID
CHEBI:15428
(2)
CHEBI:15741
(2)
CHEBI:15756
(2)
CHEBI:15978
(2)
CHEBI:16113
(2)
CHEBI:16540
(2)
CHEBI:16865
(2)
CHEBI:16958
(2)
CHEBI:17270
(2)
CHEBI:17596
(2)
CHEBI:17797
(2)
CHEBI:18237
(2)
CHEBI:18257
(2)
CHEBI:25094
(2)
CHEBI:29864
(2)
CHEBI:30831
(2)
CHEBI:32154
(2)
CHEBI:33508
(2)
CHEBI:340824
(2)
CHEBI:6650
(2)
CHEBI:73990
(2)
CHEBI:75342
(2)
CHEBI:88003
(2)
CHEBI:131739
(1)
CHEBI:131982
(1)
CHEBI:131985
(1)
CHEBI:133032
(1)
CHEBI:134594
(1)
CHEBI:136083
(1)
CHEBI:136140
(1)
Metabolite Name
Malic acid
(2)
Succinic acid
(2)
1,3-Diaminopropane
(1)
1-Methylnicotinamide
(1)
1-Monooleoylglycerol
(1)
1-Monopalmitoylglycerol
(1)
1-Pyrroline-3-hydroxy-5-carboxylic acid
(1)
1-Tetradecanoyl-sn-glycero-3-phosphate
(1)
11-Eicosenoic acid
(1)
2-Hydroxypyridine
(1)
2-Monooleoylglycerol
(1)
2-Oxobutanoic acid
(1)
3-Aminoisobutanoic acid
(1)
3-Hydroxybutyric acid
(1)
4-Aminobutanoic acid
(1)
5-Thymidylic acid
(1)
6-Phosphogluconic acid
(1)
7Z,10Z-Hexadecadienoic acid
(1)
9Z-Heptadecenoic acid
(1)
Adenosine
(1)
Adenosine monophosphate
(1)
Alanine
(1)
Allopurinol
(1)
Arabinose
(1)
Arachidonic acid
(1)
Aspartic acid
(1)
CDP
(1)
Carbonic acid
(1)
Catelaidic acid
(1)
Cellobiose
(1)
First Public Date
2025
(29)
2024
(17)
2023
(14)
2014
(14)
2020
(12)
2022
(10)
2019
(6)
2026
(5)
2018
(5)
2021
(3)
2016
(3)
2017
(1)
2013
(1)
Modelling Approach
Computational model
(4)
Regression method
(1)
Lab affiliation
Biozentrum Basel, University of Basel, Basel, Switzerland
(1)
Department of Biochemistry, Federal University of São Paulo, Brazil.
(1)
Drug Discovery Moffitt Cancer Center Tampa, FL, USA
(1)
Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Netherlands
(1)
Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research, Center for Precision Cancer Medicine
(1)
Principal Investigator Centre for Targeted Protein Degradation University of dundee
(1)
TUM School of Natural Sciences, Department Biosciences, Chair of Organic Chemistry II, Center for Functional Protein Assemblies (CPA), Technical University Munich (TUM), Ernst-Otto-Fischer Str. 8, Garching, 85748, Germany
(1)
Université Paris Cité, CNRS, UMR7126 Epigenetics and Cell Fate, 75013 Paris, France
(1)
Tags
pathogen
(6)
xref:PubMed:41265435
(4)
xref:PubMed:40269157
(4)
xref:PubMed:35351890
(3)
xref:PubMed:36575215
(3)
xref:PubMed:36969743
(3)
xref:PubMed:39160174
(3)
xref:PubMed:23717205
(3)
xref:PubMed:36797499
(3)
xref:PubMed:40838989
(3)
pathogen:protozoan
(3)
xref:PubMed:37031341
(2)
xref:PubMed:37095322
(2)
xref:PubMed:33296667
(2)
xref:PubMed:38562800
(2)
xref:PubMed:35205675
(2)
xref:PubMed:40722937
(2)
xref:PubMed:41160705
(2)
xref:PubMed:32017074
(2)
xref:PubMed:35406487
(2)
xref:PubMed:33117517
(2)
xref:PubMed:41509293
(2)
pathogen:bacterium
(2)
xref:PubMed:23144254
(1)
xref:PubMed:38443644
(1)
xref:PubMed:35972069
(1)
xref:PubMed:31978326
(1)
xref:PubMed:37470822
(1)
xref:PubMed:32060325
(1)
xref:PubMed:31073170
(1)
IsPrivate
False
(5)
Submitter Keywords
Ersilia
(5)
FAIR-AIML
(5)
Machine Learning Model
(5)
Classification
protozoa
(3)
bacteria
(2)
fungi
(1)
Modification
2x(15)N labeled L-lysine
(1)
4x(15)N labeled L-arginine
(1)
Study type
Transcription profiling by array
(10)
RNA-seq of coding RNA
(2)
ChIP-seq
(1)
Methylation profiling by high throughput sequencing
(1)
Release Date
2024
(81)
2023
(76)
2025
(66)
2022
(64)
2021
(52)
2020
(34)
2018
(28)
2015
(24)
2019
(20)
2016
(18)
2017
(17)
2014
(15)
2012
(13)
2013
(12)
2026
(10)
2011
(9)
2008
(6)
2010
(6)
2009
(5)
2007
(3)
2006
(1)
2005
(1)
2001
(1)
Previous
page
1 / 71
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
71
Next
page
Sort
by:
Relevance
Page size
10
De novo design of high-affinity binders of bioactive helical peptides.
Not available
S-EPMC10849960
|
biostudies-literature
Cite
LEADD: Lamarckian evolutionary algorithm for de novo drug design.
Not available
S-EPMC8760751
|
biostudies-literature
Cite
Enhancing
De Novo
Drug Design across Multiple Therapeutic Targets with CVAE Generative Models.
Not available
S-EPMC11525747
|
biostudies-literature
Cite
Structure-based
de novo
drug design using 3D deep generative models.
Not available
S-EPMC8549794
|
biostudies-literature
Cite
Prospective de novo drug design with deep interactome learning.
Not available
S-EPMC11035696
|
biostudies-literature
Cite
<i>De novo</i> design of miniprotein agonists and antagonists targeting G protein-coupled receptors.
Not available
S-EPMC12157396
|
biostudies-literature
Cite
Generate what you can make: achieving in-house synthesizability with readily available resources in de novo drug design.
Not available
S-EPMC11954305
|
biostudies-literature
Cite
LigBuilder V3: A Multi-Target
de novo
Drug Design Approach.
Not available
S-EPMC7059350
|
biostudies-literature
Cite
Multi-and many-objective optimization: present and future in
de novo
drug design.
Not available
S-EPMC10773868
|
biostudies-literature
Cite
Multi-objective de novo drug design with conditional graph generative model.
Not available
S-EPMC6057868
|
biostudies-literature
Cite
Previous
page
1 / 71
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
71
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
